Mitchell S. Steiner,Mary Ann Johnston,Michael L. Hancock,Jeffrey G. Hesselberg,James T. Dalton
申请号:
US14062748
公开号:
US20140134274A1
申请日:
2013.10.24
申请国别(地区):
US
年份:
2014
代理人:
摘要:
This invention provides use of a SARM compound or a composition comprising the same in treating and preventing muscle wasting in patients with non-small cell lung cancer (NSCLC) treating pre-cachexia or early cachexia (preventing muscle wasting in a cancer patient) treating and preventing loss of physical function due to cancer or cancer therapy increase of physical function and increasing survival in a patient with NSCLC, wherein the patients are subjected to cancer therapy.